Statistics from Altmetric.com
Although visual results after use of the new surgical method of retinal endovascular lysis (REVL) seem encouraging,1,2 its effectiveness has not been proved in a controlled, prospective clinical trial. From a histological postmortem study of eyes with central retinal vein occlusion (CRVO), it is still questionable whether an older thrombus can be dissolved using recombinant tissue plasminogen activator (rt-PA).3 We report on the histopathological findings in a human eye 9 months after REVL.
We report the case of a 62-year-old woman having a 7-week-old, highly ischaemic CRVO in her left eye with hand movement vision. Although we were concerned about treating …